Clinical Trial Update: Monitoring of Patients Followed for a Multiple Sclerosis and Treated by Dimethyl-fumarate [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update monitoring patients with relapsing-remitting multiple sclerosis treated with dimethyl fumarate.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis Relapsing-remitting

Drugs mentioned

• Dimethyl fumarate (Dimethyl fumarate)

Snippet

Sponsor: Fondation Ophtalmologique Adolphe de Rothschild | Conditions: Multiple Sclerosis, Relapsing-Remitting | Phase 4 | Status: TERMINATED